1. Home
  2. ATLO vs GBIO Comparison

ATLO vs GBIO Comparison

Compare ATLO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLO
  • GBIO
  • Stock Information
  • Founded
  • ATLO 1903
  • GBIO 2016
  • Country
  • ATLO United States
  • GBIO United States
  • Employees
  • ATLO N/A
  • GBIO N/A
  • Industry
  • ATLO Major Banks
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATLO Finance
  • GBIO Health Care
  • Exchange
  • ATLO Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ATLO 180.3M
  • GBIO 41.2M
  • IPO Year
  • ATLO N/A
  • GBIO 2020
  • Fundamental
  • Price
  • ATLO $20.86
  • GBIO $5.51
  • Analyst Decision
  • ATLO
  • GBIO Buy
  • Analyst Count
  • ATLO 0
  • GBIO 4
  • Target Price
  • ATLO N/A
  • GBIO $10.67
  • AVG Volume (30 Days)
  • ATLO 23.7K
  • GBIO 49.6K
  • Earning Date
  • ATLO 10-17-2025
  • GBIO 11-07-2025
  • Dividend Yield
  • ATLO 3.83%
  • GBIO N/A
  • EPS Growth
  • ATLO 82.22
  • GBIO N/A
  • EPS
  • ATLO 1.79
  • GBIO N/A
  • Revenue
  • ATLO $60,568,000.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • ATLO N/A
  • GBIO N/A
  • Revenue Next Year
  • ATLO N/A
  • GBIO N/A
  • P/E Ratio
  • ATLO $11.64
  • GBIO N/A
  • Revenue Growth
  • ATLO 18.60
  • GBIO 61.15
  • 52 Week Low
  • ATLO $15.75
  • GBIO $3.00
  • 52 Week High
  • ATLO $21.48
  • GBIO $25.70
  • Technical
  • Relative Strength Index (RSI)
  • ATLO 57.02
  • GBIO 36.99
  • Support Level
  • ATLO $20.68
  • GBIO $5.36
  • Resistance Level
  • ATLO $21.00
  • GBIO $6.47
  • Average True Range (ATR)
  • ATLO 0.44
  • GBIO 0.29
  • MACD
  • ATLO 0.06
  • GBIO -0.13
  • Stochastic Oscillator
  • ATLO 68.42
  • GBIO 9.62

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: